Parallax Volatility Advisers
ONC

Parallax Volatility Advisers’s BeOne Medicines Ltd ONC Stock Holding History

Parallax Volatility Advisers’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-1,000
Closed -$216K – 2945
2023
Q1 		$216K Hold
1,000
– – ﹤0.01% 1975
2022
Q4 		$220K Buy
+1,000
New +$183K ﹤0.01% 2110
2018
Q2 		– Sell
-82,000
Closed -$13.8M – 3514
2018
Q1 		$13.8M Buy
+82,000
New +$11.1M 0.02% 319
2017
Q4 		– Sell
-10,000
Closed -$1.03M – 5105
2017
Q3 		$1.03M Buy
+10,000
New +$745K ﹤0.01% 1056

Other funds holding ONC

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
CII
Capital International Inc Los Angeles, California $13B AUM 31.88% 1-Year Est. Return

Parallax Volatility Advisers's ONC Position: Q3 2019 in Review

Parallax Volatility Advisers sold out of BeOne Medicines Ltd (ONC) in Q3 2019, closing a stake of 20 shares — an estimated $2K sold.

Parallax Volatility Advisers first reported a position in ONC in Q2 2019 and held it in 1 quarter. The position peaked at $2K in Q2 2019. 196 funds tracked by Wall St. Rank hold ONC as of Q3 2019.

  • Parallax Volatility Advisers reported no remaining BeOne Medicines Ltd position as of Q3 2019 after selling out during the quarter.
  • Parallax Volatility Advisers sold 20 BeOne Medicines Ltd shares in Q3 2019, an estimated $2K.
  • Parallax Volatility Advisers first reported a position in BeOne Medicines Ltd in Q2 2019 and held it in 1 quarter.
  • Parallax Volatility Advisers's BeOne Medicines Ltd position peaked at $2K in Q2 2019.
  • 196 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q3 2019.

Based on Parallax Volatility Advisers's 13F filing for Q3 2019, filed 14 Nov 2019.